{
  "id": 5446,
  "text": "Gynecol Oncol 2001;81:213-215.Available at: http://www.ncbi.nlm.nih.gov/pubmed/11354055.264.Muggia FM, Blessing JA, Method M, et al.Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Gynecol Oncol 2001;81:213-215.Available at: http://www.ncbi.nlm.nih.gov/pubmed/11354055.264.Muggia FM, Blessing JA, Method M, et al.Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "长春瑞滨（vinorelbine）确实在宫颈鳞状细胞癌的治疗中进行了评估。根据妇科肿瘤学组的一项研究，长春瑞滨被用于持续或复发性宫颈鳞状细胞癌的治疗，以了解其效果。这项研究的目的是确定长春瑞滨在这种类型的宫颈癌中的疗效和安全性。研究结果为医疗提供了有关药物作用的宝贵信息，从而为临床治疗方案的制定提供依据。",
  "query": "宫颈癌治疗中是否曾经评估过长春瑞滨（vinorelbine）的效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌治疗中是否曾经评估过长春瑞滨（vinorelbine）的效果？\n\n<reference text>: Gynecol Oncol 2001;81:213-215.Available at: http://www.ncbi.nlm.nih.gov/pubmed/11354055.264.Muggia FM, Blessing JA, Method M, et al.Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "长春瑞滨（vinorelbine）确实在宫颈鳞状细胞癌的治疗中进行了评估。根据妇科肿瘤学组的一项研究，长春瑞滨被用于持续或复发性宫颈鳞状细胞癌的治疗，以了解其效果。这项研究的目的是确定长春瑞滨在这种类型的宫颈癌中的疗效和安全性。研究结果为医疗提供了有关药物作用的宝贵信息，从而为临床治疗方案的制定提供依据。"
}